Loading…
Insulin-Mimetic Action of Vanadate: Role of Intracellular Magnesium
The insulin-mimetic effect of vanadate is well established, and vanadate has been shown to improve insulin sensitivity in diabetic rats and humans. Although the exact mechanism(s) remain undefined, we have previously demonstrated a direct relation of intracellular free magnesium (Mgi) levels to gluc...
Saved in:
Published in: | Hypertension (Dallas, Tex. 1979) Tex. 1979), 2001-09, Vol.38 (3, Part 2 Suppl), p.701-704 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c3885-b0344a25b9996f6934b89e51395408527d70e9ee2be7e8bbc0d1ed27e7a4613f3 |
container_end_page | 704 |
container_issue | 3, Part 2 Suppl |
container_start_page | 701 |
container_title | Hypertension (Dallas, Tex. 1979) |
container_volume | 38 |
creator | Barbagallo, Mario Dominguez, Ligia J Resnick, Lawrence M |
description | The insulin-mimetic effect of vanadate is well established, and vanadate has been shown to improve insulin sensitivity in diabetic rats and humans. Although the exact mechanism(s) remain undefined, we have previously demonstrated a direct relation of intracellular free magnesium (Mgi) levels to glucose disposal, to insulinemic responses following glucose loading, and to insulin-induced ionic effects. To investigate whether the insulin-mimetic effects of vanadate could similarly be mediated by Mgi, we utilized P-nuclear magnetic resonance spectroscopy to measure Mgi in erythrocytes from normal (NL, n=10) and hypertensive (HTN, n=12) subjects, before and after incubation with insulin and with different doses of sodium vanadate. In NL, vanadate elevated Mgi levels, with maximum efficacy at 50 7mgr;mol/L (186±6 to 222±6 7mgr;mol/L, P >0.01), as did physiologically maximal doses of insulin, 200 7mgr;U/mL (185±6 to 222±8 7mgr;mol/L, P |
doi_str_mv | 10.1161/hy09t1.095392 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71187844</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>84533331</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3885-b0344a25b9996f6934b89e51395408527d70e9ee2be7e8bbc0d1ed27e7a4613f3</originalsourceid><addsrcrecordid>eNpd0U1r3DAQBmBRGppt0mOvxRTam1KNviz1FpZ-LCQESlp6E7I97jqV5USyCfn31eKFQOeggeFhGF4R8hbYBYCGT_snZme4YFYJy1-QDSguqVRavCQbBlZSC_D7lLzO-Y4xkFLWr8gpgNLaarYh213MSxgivR5GnIe2umznYYrV1Fe_fPSdn_Fz9WMKeJjs4px8iyEswafq2v-JmIdlPCcnvQ8Z3xz7Gfn59cvt9ju9uvm2215e0VYYo2jDhJSeq8Zaq3tthWyMRQXCKsmM4nVXM7SIvMEaTdO0rAPseI21lxpEL87Ix3XvfZoeFsyzG4d8OMdHnJbsagBTGykLfP8fvJuWFMttjjMlWDGmILqiNk05J-zdfRpGn54cMHeI1q3RujXa4t8dly7NiN2zPmZZwIcj8Ln1oU8-tkN-dhIYaKmLk6t7nMKMKf8NyyMmt0cf5r1jpSTXhvLyXcyWh5aJUOIfLMKO2A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>205308448</pqid></control><display><type>article</type><title>Insulin-Mimetic Action of Vanadate: Role of Intracellular Magnesium</title><source>EZB Electronic Journals Library</source><creator>Barbagallo, Mario ; Dominguez, Ligia J ; Resnick, Lawrence M</creator><creatorcontrib>Barbagallo, Mario ; Dominguez, Ligia J ; Resnick, Lawrence M</creatorcontrib><description>The insulin-mimetic effect of vanadate is well established, and vanadate has been shown to improve insulin sensitivity in diabetic rats and humans. Although the exact mechanism(s) remain undefined, we have previously demonstrated a direct relation of intracellular free magnesium (Mgi) levels to glucose disposal, to insulinemic responses following glucose loading, and to insulin-induced ionic effects. To investigate whether the insulin-mimetic effects of vanadate could similarly be mediated by Mgi, we utilized P-nuclear magnetic resonance spectroscopy to measure Mgi in erythrocytes from normal (NL, n=10) and hypertensive (HTN, n=12) subjects, before and after incubation with insulin and with different doses of sodium vanadate. In NL, vanadate elevated Mgi levels, with maximum efficacy at 50 7mgr;mol/L (186±6 to 222±6 7mgr;mol/L, P >0.01), as did physiologically maximal doses of insulin, 200 7mgr;U/mL (185±6 to 222±8 7mgr;mol/L, P <0.01). In HTN, only vanadate, but not insulin, increased Mgi (insulin173±7 to 180±9 7mgr;mol/L, P =NS; vanadate170±7 to 208±10 7mgr;mol/L, P <0.01). Mgi responses to insulin (r =0.637, P <0.001), but not to vanadate (r =0.15, P =NS), were closely and directly related to basal Mgi levels. We conclude that (1) both vanadate and insulin stimulate erythrocyte Mgi levels; (2) cellular Mgi responses to insulin, but not to vanadate, depend on basal Mgi content—the lower the basal Mgi, the less the Mgi response to insulin. As such, (3) Mgi responses to vanadate were equivalent among HTN and NL, whereas HTN cells exhibited blunted Mgi responses to insulin, and (4) the ability of vanadate to improve insulin sensitivity clinically may be mediated, at least in part, by its ability to increase Mgi levels, which in turn, helps to determine cellular insulin action.</description><identifier>ISSN: 0194-911X</identifier><identifier>EISSN: 1524-4563</identifier><identifier>DOI: 10.1161/hy09t1.095392</identifier><identifier>PMID: 11566960</identifier><identifier>CODEN: HPRTDN</identifier><language>eng</language><publisher>Philadelphia, PA: American Heart Association, Inc</publisher><subject>Apud cells. Peptide and protein hormones. Growth factors ; Biological and medical sciences ; Dose-Response Relationship, Drug ; Erythrocytes - cytology ; Erythrocytes - drug effects ; Erythrocytes - metabolism ; Female ; Fundamental and applied biological sciences. Psychology ; Humans ; Hypertension - blood ; Insulin - pharmacology ; Magnesium - blood ; Magnetic Resonance Spectroscopy ; Male ; Time Factors ; Vanadates - pharmacology ; Vertebrates: endocrinology</subject><ispartof>Hypertension (Dallas, Tex. 1979), 2001-09, Vol.38 (3, Part 2 Suppl), p.701-704</ispartof><rights>2001 American Heart Association, Inc.</rights><rights>2002 INIST-CNRS</rights><rights>Copyright American Heart Association, Inc. Sep 2001</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3885-b0344a25b9996f6934b89e51395408527d70e9ee2be7e8bbc0d1ed27e7a4613f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14101646$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11566960$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Barbagallo, Mario</creatorcontrib><creatorcontrib>Dominguez, Ligia J</creatorcontrib><creatorcontrib>Resnick, Lawrence M</creatorcontrib><title>Insulin-Mimetic Action of Vanadate: Role of Intracellular Magnesium</title><title>Hypertension (Dallas, Tex. 1979)</title><addtitle>Hypertension</addtitle><description>The insulin-mimetic effect of vanadate is well established, and vanadate has been shown to improve insulin sensitivity in diabetic rats and humans. Although the exact mechanism(s) remain undefined, we have previously demonstrated a direct relation of intracellular free magnesium (Mgi) levels to glucose disposal, to insulinemic responses following glucose loading, and to insulin-induced ionic effects. To investigate whether the insulin-mimetic effects of vanadate could similarly be mediated by Mgi, we utilized P-nuclear magnetic resonance spectroscopy to measure Mgi in erythrocytes from normal (NL, n=10) and hypertensive (HTN, n=12) subjects, before and after incubation with insulin and with different doses of sodium vanadate. In NL, vanadate elevated Mgi levels, with maximum efficacy at 50 7mgr;mol/L (186±6 to 222±6 7mgr;mol/L, P >0.01), as did physiologically maximal doses of insulin, 200 7mgr;U/mL (185±6 to 222±8 7mgr;mol/L, P <0.01). In HTN, only vanadate, but not insulin, increased Mgi (insulin173±7 to 180±9 7mgr;mol/L, P =NS; vanadate170±7 to 208±10 7mgr;mol/L, P <0.01). Mgi responses to insulin (r =0.637, P <0.001), but not to vanadate (r =0.15, P =NS), were closely and directly related to basal Mgi levels. We conclude that (1) both vanadate and insulin stimulate erythrocyte Mgi levels; (2) cellular Mgi responses to insulin, but not to vanadate, depend on basal Mgi content—the lower the basal Mgi, the less the Mgi response to insulin. As such, (3) Mgi responses to vanadate were equivalent among HTN and NL, whereas HTN cells exhibited blunted Mgi responses to insulin, and (4) the ability of vanadate to improve insulin sensitivity clinically may be mediated, at least in part, by its ability to increase Mgi levels, which in turn, helps to determine cellular insulin action.</description><subject>Apud cells. Peptide and protein hormones. Growth factors</subject><subject>Biological and medical sciences</subject><subject>Dose-Response Relationship, Drug</subject><subject>Erythrocytes - cytology</subject><subject>Erythrocytes - drug effects</subject><subject>Erythrocytes - metabolism</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Hypertension - blood</subject><subject>Insulin - pharmacology</subject><subject>Magnesium - blood</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Male</subject><subject>Time Factors</subject><subject>Vanadates - pharmacology</subject><subject>Vertebrates: endocrinology</subject><issn>0194-911X</issn><issn>1524-4563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNpd0U1r3DAQBmBRGppt0mOvxRTam1KNviz1FpZ-LCQESlp6E7I97jqV5USyCfn31eKFQOeggeFhGF4R8hbYBYCGT_snZme4YFYJy1-QDSguqVRavCQbBlZSC_D7lLzO-Y4xkFLWr8gpgNLaarYh213MSxgivR5GnIe2umznYYrV1Fe_fPSdn_Fz9WMKeJjs4px8iyEswafq2v-JmIdlPCcnvQ8Z3xz7Gfn59cvt9ju9uvm2215e0VYYo2jDhJSeq8Zaq3tthWyMRQXCKsmM4nVXM7SIvMEaTdO0rAPseI21lxpEL87Ix3XvfZoeFsyzG4d8OMdHnJbsagBTGykLfP8fvJuWFMttjjMlWDGmILqiNk05J-zdfRpGn54cMHeI1q3RujXa4t8dly7NiN2zPmZZwIcj8Ln1oU8-tkN-dhIYaKmLk6t7nMKMKf8NyyMmt0cf5r1jpSTXhvLyXcyWh5aJUOIfLMKO2A</recordid><startdate>200109</startdate><enddate>200109</enddate><creator>Barbagallo, Mario</creator><creator>Dominguez, Ligia J</creator><creator>Resnick, Lawrence M</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>200109</creationdate><title>Insulin-Mimetic Action of Vanadate: Role of Intracellular Magnesium</title><author>Barbagallo, Mario ; Dominguez, Ligia J ; Resnick, Lawrence M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3885-b0344a25b9996f6934b89e51395408527d70e9ee2be7e8bbc0d1ed27e7a4613f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Apud cells. Peptide and protein hormones. Growth factors</topic><topic>Biological and medical sciences</topic><topic>Dose-Response Relationship, Drug</topic><topic>Erythrocytes - cytology</topic><topic>Erythrocytes - drug effects</topic><topic>Erythrocytes - metabolism</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Hypertension - blood</topic><topic>Insulin - pharmacology</topic><topic>Magnesium - blood</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Male</topic><topic>Time Factors</topic><topic>Vanadates - pharmacology</topic><topic>Vertebrates: endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Barbagallo, Mario</creatorcontrib><creatorcontrib>Dominguez, Ligia J</creatorcontrib><creatorcontrib>Resnick, Lawrence M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barbagallo, Mario</au><au>Dominguez, Ligia J</au><au>Resnick, Lawrence M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Insulin-Mimetic Action of Vanadate: Role of Intracellular Magnesium</atitle><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle><addtitle>Hypertension</addtitle><date>2001-09</date><risdate>2001</risdate><volume>38</volume><issue>3, Part 2 Suppl</issue><spage>701</spage><epage>704</epage><pages>701-704</pages><issn>0194-911X</issn><eissn>1524-4563</eissn><coden>HPRTDN</coden><abstract>The insulin-mimetic effect of vanadate is well established, and vanadate has been shown to improve insulin sensitivity in diabetic rats and humans. Although the exact mechanism(s) remain undefined, we have previously demonstrated a direct relation of intracellular free magnesium (Mgi) levels to glucose disposal, to insulinemic responses following glucose loading, and to insulin-induced ionic effects. To investigate whether the insulin-mimetic effects of vanadate could similarly be mediated by Mgi, we utilized P-nuclear magnetic resonance spectroscopy to measure Mgi in erythrocytes from normal (NL, n=10) and hypertensive (HTN, n=12) subjects, before and after incubation with insulin and with different doses of sodium vanadate. In NL, vanadate elevated Mgi levels, with maximum efficacy at 50 7mgr;mol/L (186±6 to 222±6 7mgr;mol/L, P >0.01), as did physiologically maximal doses of insulin, 200 7mgr;U/mL (185±6 to 222±8 7mgr;mol/L, P <0.01). In HTN, only vanadate, but not insulin, increased Mgi (insulin173±7 to 180±9 7mgr;mol/L, P =NS; vanadate170±7 to 208±10 7mgr;mol/L, P <0.01). Mgi responses to insulin (r =0.637, P <0.001), but not to vanadate (r =0.15, P =NS), were closely and directly related to basal Mgi levels. We conclude that (1) both vanadate and insulin stimulate erythrocyte Mgi levels; (2) cellular Mgi responses to insulin, but not to vanadate, depend on basal Mgi content—the lower the basal Mgi, the less the Mgi response to insulin. As such, (3) Mgi responses to vanadate were equivalent among HTN and NL, whereas HTN cells exhibited blunted Mgi responses to insulin, and (4) the ability of vanadate to improve insulin sensitivity clinically may be mediated, at least in part, by its ability to increase Mgi levels, which in turn, helps to determine cellular insulin action.</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>11566960</pmid><doi>10.1161/hy09t1.095392</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0194-911X |
ispartof | Hypertension (Dallas, Tex. 1979), 2001-09, Vol.38 (3, Part 2 Suppl), p.701-704 |
issn | 0194-911X 1524-4563 |
language | eng |
recordid | cdi_proquest_miscellaneous_71187844 |
source | EZB Electronic Journals Library |
subjects | Apud cells. Peptide and protein hormones. Growth factors Biological and medical sciences Dose-Response Relationship, Drug Erythrocytes - cytology Erythrocytes - drug effects Erythrocytes - metabolism Female Fundamental and applied biological sciences. Psychology Humans Hypertension - blood Insulin - pharmacology Magnesium - blood Magnetic Resonance Spectroscopy Male Time Factors Vanadates - pharmacology Vertebrates: endocrinology |
title | Insulin-Mimetic Action of Vanadate: Role of Intracellular Magnesium |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T14%3A26%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Insulin-Mimetic%20Action%20of%20Vanadate:%20Role%20of%20Intracellular%20Magnesium&rft.jtitle=Hypertension%20(Dallas,%20Tex.%201979)&rft.au=Barbagallo,%20Mario&rft.date=2001-09&rft.volume=38&rft.issue=3,%20Part%202%20Suppl&rft.spage=701&rft.epage=704&rft.pages=701-704&rft.issn=0194-911X&rft.eissn=1524-4563&rft.coden=HPRTDN&rft_id=info:doi/10.1161/hy09t1.095392&rft_dat=%3Cproquest_cross%3E84533331%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3885-b0344a25b9996f6934b89e51395408527d70e9ee2be7e8bbc0d1ed27e7a4613f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=205308448&rft_id=info:pmid/11566960&rfr_iscdi=true |